Shropshire Thomas B Jr.
Known title: SVP and General CounselCIK: 0002070785
Associated companies
Transaction History
| TMO | ▼ Sell | Tax Withholding | 49 | $31K | 8/28/2026 | View on chart |
| TMO | ▲ Buy | Grant | 978 | $0 | 2/25/2026 | View on chart |
| TMO | ▼ Sell | Tax Withholding | 337 | $196K | 12/2/2025 | View on chart |
| TMO | ▲ Buy | Grant | 5,417 | $0 | 6/2/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Thermo Fisher Outperforms on Life Sciences Recovery
Thermo Fisher Scientific reported strong results driven by a recovery in the life sciences sector. Growth in academic and government spending is supporting demand for the company's products. Analysts note that increasing omics demand could further influence the stock's outlook.
Thermo Fisher Outperforms on Life Sciences Recovery. Thermo Fisher Scientific reported strong results driven by a recovery in the life sciences sector. Growth in academic and government spending is supporting demand for the company's products. Analysts note that increasing omics demand could further influence the stock's outlook.